Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in JapanResearch in context

Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in JapanResearch in context

Summary: Background: Autoimmune inflammatory rheumatic disease (AIRD) patients are at high risk of the coronavirus disease 2019 (COVID-19), but the medium-term effects of immunosuppressants on vaccine efficacy are unknown. We investigated the duration of humoral responses against severe acute respi...

Full description

Bibliographic Details
Main Authors: Yuta Yamaguchi, Shinichiro Nameki, Yasuhiro Kato, Ryotaro Saita, Tomoharu Sato, Sayaka Nagao, Teruaki Murakami, Yuko Yoshimine, Saori Amiya, Takayoshi Morita, Yasutaka Okita, Takahiro Kawasaki, Jun Fujimoto, Yasutaka Ueda, Yuichi Maeda, Akane Watanabe, Hyota Takamatsu, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Atsushi Kumanogoh
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:The Lancet Regional Health. Western Pacific
Subjects:
SARS-CoV-2
BNT162b2 mRNA vaccine
SARS-CoV-2 Omicron variant
Humoral response
Autoimmune inflammatory rheumatic disease
Online Access:http://www.sciencedirect.com/science/article/pii/S2666606522002760

Internet

http://www.sciencedirect.com/science/article/pii/S2666606522002760

Similar Items